Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
FDA Should Delay Provenge Decision Pending Definitive Trial Results, ODAC Chairman Writes.
This article is from
The Cancer Letter
archive.
Vol. 33 No. 16 | April 27, 2007
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
Talactoferrin Second-Line Therapy Increases Survival In Stage IIIB/IV
October 28, 2011
TCL Archive
Publisher, Law Firm Settle Suit Over Newsletter Photocopy
November 15, 1991
TCL Archive
Kramer Says New Radiotherapy Could Save 1.3 Of Failures
February 18, 1977
TCL Archive
DCE Board Approves Reissuing Epidemiology Small Grants PA
June 3, 1988
TCL Archive
US Oncology Renegotiates Agreements To Operate Under Net Earnings Model.
March 30, 2001
TCL Archive
Univ. of Iowa Cancer Center Wins NCI Cancer Center Grant.
July 28, 2000